meeting-5804489_1920

Learn About Our Speakers

Al-Samkari, Hanny MD_MGH

Hanny Al-Samkari, MD
Associate Director, HHT Center of Excellence, Massachusetts General Hospital

Dr. Al-Samkari is a hematologist and clinical investigator at the Massachusetts General Hospital (MGH) and Harvard Medical School, as well as the Associate Director of the MGH HHT Center of Excellence. He received his medical degree from Washington University in St. Louis, completed his residency in internal medicine at the Hospital of the University of Pennsylvania (where he also served as Chief Medical Resident), and completed his fellowship in hematology and medical oncology at the Dana-Farber Cancer Institute-Massachusetts General Hospital combined program.
He specializes in disorders of bleeding and clotting as well as hemolytic anemias. This includes hereditary hemorrhagic telangiectasia, coagulation defects, platelet disorders, and a number of hereditary hemolytic anemias including red cell enzymatic defects. As a clinical investigator, Dr. Al-Samkari serves as the principal investigator for several clinical trials at any given time in HHT and other hematologic diseases, enabling him to offer new and promising treatment options to these patients.
Chakinala, Murali M.D.

Murali Chakinala, MD
Co-Director, HHT Center of Excellence, Washington University

Dr. Chakinala is a Professor in the Department of Internal Medicine, Director of the Pulmonary Hypertension Care Center and Co-Director of the HHT Center at Washington University. He is chair of the Scientific Leadership Council of the Pulmonary Hypertension Association, immediate-past chair of Pulmonary Hypertension Care Centers Oversight Committee, and member of Cure HHT’s Global Research Medical Advisory Board

Dr. Chakinala received his undergraduate education at Duke University and then received his medical degree at Vanderbilt University School of Medicine. He completed an Internal Medicine Residency at the University of Texas – Southwestern, and also served as a Chief Resident. He finished his Pulmonary and Critical Care training at Washington University in 2002 and then joined the faculty. He is board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine. His interests include clinical management and clinical research in the areas of pulmonary hypertension, pulmonary arterio-venous malformations, pulmonary thrombo-embolic diseases, and end-stage lung diseases. 

Faughnan-Marie Toronto

Marie E. Faughnan, MD, MSc
Director, HHT Center of Excellence, University of Toronto and St. Michael’s Hospital

Dr. Faughnan is a staff pulmonologist, Professor of Medicine, and clinician investigator at St. Michael’s Hospital and University of Toronto. She has a special interest in pulmonary arteriovenous malformations and HHT. Dr. Faughnan’s degrees include an M.D. from Universite de Montreal (1993) and an MSc in Clinical Epidemiology (2000) from the University of Toronto. She is presently the Director of the HHT Program at St. Michael’s Hospital / University of Toronto and serves on several Cure HHT committees and advisory boards.
Hammill, Adrienne

Adrienne Hammill, MD, Ph.D.
Director, HHT Center of Excellence, Cincinnati Children’s Hospital

Dr. Adrienne Hammill is an Associate Professor of Pediatrics at the University of Cincinnati. She is research director of the Hemangioma and Vascular Malformations Center and also participates in the Cerebrovascular Clinic. She obtained her schooling at the University of Texas Southwestern and completed her residency and fellowship at Cincinnati Children’s Hospital Medical Center.

Dr. Hammill leads the adult and pediatric teams at the HHT Center working in tandem to provide seamless care across the lifespan, with particular expertise in treating children with brain and lung AVMs. 

Iyer, Vivek MD

Vivek N. Iyer, MD
Director, HHT Center of Excellence, Mayo Clinic

Dr. Vivek Iyer is an Associate Professor of Medicine at the Mayo Clinic College of Medicine and Science and a consultant in the Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine at Mayo Clinic in Rochester. Dr. Iyer earned his M.B.B.S and M.D. degree with a specialization in internal medicine at B. J. Medical College in Ahmedabad, India. He earned his M.P.H. degree at Columbia University and a residency in internal medicine at State University of New York at Buffalo, New York. He further completed a fellowship in critical care medicine and a fellowship in pulmonary medicine at Mayo Clinic.

Dr. Iyer is certified in clinical research through Mayo School of Graduate Medical Education and is certified as a Mayo Clinic Quality Fellow: Silver Level through Mayo Clinic Quality Academy. Dr. Iyer’s clinical interests focus on pulmonary vascular diseases such HHT, HPS and POPH and upper airway disorders (chronic cough, asthma, vocal cord dysfunction). He also practices critical care medicine.  

kasthuri_1.jpg

Raj S. Kasthuri, MD
Director, HHT Center of Excellence, University of North Carolina at Chapel Hill

Dr. Kasthuri is Professor of Medicine in the Division of Hematology at the University of North Carolina at Chapel Hill.  He completed his fellowship in Hematology, Oncology and Bone Marrow Transplantation at the University of Minnesota in 2005. Dr. Kasthuri’s clinical and research interests are in disorders of Hemostasis and Thrombosis, and Hereditary Hemorrhagic Telangiectasia (HHT).  He is Director of the UNC HHT Center of Excellence, and Associate Director for Clinical Research at the UNC Blood Research Center.

Lausman, Andrea MD_cropped

Andrea Lausman, MD
Maternal Fetal Medicine Specialist, HHT Center of Excellence, University of Toronto and St. Michael’s Hospital

Dr. Lausman is currently an Assistant Professor at the University of Toronto and maternal-fetal medicine specialist and head of Labor and Delivery at St. Michael’s Hospital. She graduated from the University of Western Ontario Medical School and completed her residency in Obstetrics and Gynecology and a two-year fellowship in Maternal-Fetal Medicine at the University of Toronto. Her research interests are varied, and include guideline development in intra-uterine growth restriction, stroke and HHT.  She is currently working with the hematologists on several prospective studies on iron deficiency in pregnancy.  

Meffe, Filomena MD_cropped

Filomena Meffe, MD, FRCSC, MSc
Chief, Obstetrics and Gynecology, HHT Center of Excellence, University of Toronto and St. Michael’s Hospital

Dr. Meffe is currently an Associate Professor in the Department of Obstetrics and Gynecology at the University of Toronto. She has a master’s degree in Clinical Epidemiology from University of Toronto and was Director of Undergraduate Medical Education, Department of Obstetrics and Gynecology, University of Toronto, from 2001 to 2013. Her clinical practice is focused of obstetrical care, gynecologic surgery and the care of women with heavy menstrual bleeding in the context of hematologic bleeding disorders (Multidisciplinary Clinic for Women with Bleeding Disorders, St. Michael’s Hospital).

McCrae, Keith, MD_cropped

Keith McCrae, MD
PI for PATH-HHT Study - Cleveland Clinic

Dr. Keith McCrae received his MD degree from Duke University and subsequently trained in Hematology-Oncology at the University of Pennsylvania. He has been a member of the faculty at U. Penn, Temple University and Case Western Reserve University, and is currently at the Cleveland Clinic where he is a Professor and Director of Benign Hematology. His interest are in bleeding, thrombotic and immune hematologic and vascular disorders. In addition to his clinical practice and clinical trials, he oversees a basic research laboratory where he studies blood and blood vessel function.

Serra, Marcelo MD - cropped

Marcelo Serra, MD
Director de la Unidad HHT, Hospital Italiano de Buenos Aires

Dr. Marcelo Serra, Director de la Unidad HHT, Hospital Italiano de Buenos Aires. El Dr. Serra es Especialista en Medicina Interna, medico staff del Servicio de Clínica Médica del Hospital Italiano de Buenos Aires, director y fundador de la Unidad HHT del Hospital Italiano de Buenos Aires, y del Grupo A.R.G (Argentine Rendu Study Group), Miembro del Cure HHT GRMAB, co-director de la Unidad de von Hippel Lindau, Director del Programa de Enfermedades Raras del Hosp Italiano, Docente de la Universidad de Buenos Aires y Profesor Adjunto del Instituto Universitario del Hospital Italiano de Buenos Aires.

????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

Andrew J. White, MD
Co-Director, HHT Center of Excellence, Washington University School of Medicine

Dr. Andrew J. White is currently Director of the Pediatric Residency Program and Director of the Division of Rheumatology and Immunology in the Department of Pediatrics at Washington University School of Medicine in St. Louis.  Dr. White obtained his M.D. in 1994 from University of Texas Southwestern Medical School.  He was an intern and resident in Pediatrics at St. Louis Children’s Hospital from 1994-1997.  After spending three years as a Pediatric Rheumatology/ Immunology fellow at Washington University School of Medicine in St. Louis from 1997-2000, he was recruited as faculty at Washington University.

Dr. White is board certified in Pediatrics and in Pediatric Rheumatology, and has held an appointment with St. Louis Children’s Hospital since 2000.